Searchable abstracts of presentations at key conferences in endocrinology

ea0090rc7.6 | Rapid Communications 7: Pituitary and Neuroendocrinology 2 | ECE2023

Acquired Hypothalamic dysfunction in childhood: “What do patients need? ”

van Roessel Ichelle , de Graaf Johan , Biermasz Nienke , Charmandari Evangelia , van Santen Hanneke

Introduction: Hypothalamic dysfunction (HD) during childhood can occur due to (treatment of) a suprasellar brain tumor. HD may not only result in pituitary dysfunction, but also in severe hyperphagia, decreased energy expenditure, diabetes insipidus with adipsia, disturbance of circadian rhythm, temperature dysregulation and behavioral problems. Currently there is no effective treatment for HD while HD has major impact on quality of life. To provide optimal care and to design ...

ea0090p686 | Pituitary and Neuroendocrinology | ECE2023

Diagnostic criteria for the hypothalamic syndrome in childhood

van Santen Hanneke , van Schaik Jiska , van Roessel Ichelle , Boekhoff Svenja , Beckhaus Julia , Muller Hermann

Objective: Hypothalamic syndrome (HS) in childhood is a rare condition. Its epidemiology is not well known because incidence and prevalence are related to very rare underlying diseases. In addition, different criteria for the syndrome are used across studies. Recognizing HS may be difficult, due to its rareness and variety of symptoms. Having diagnostic criteria for signs and symptoms of hypothalamic dysfunction may aid in early recognition and diagnosis, in the reporting and ...

ea0090p31 | Calcium and Bone | ECE2023

Bone mineral density in children and adolescents with Cystic Fibrosis

Tamer Gizem , Gerardus Maria Arets Hubertus , Kors van der Ent Cornelis , Margo van Santen Hanneke , Jacoba van der Kamp Hetty

Background: Bone health can be affected in (young) adults with Cystic Fibrosis (CF) due to different risk factors in childhood. We aimed to analyze the prevalence of low bone mineral density (BMD) during childhood in patients with CF, its risk factors and course in time.Methods: A longitudinal prospective cohort study was performed in children with CF aged 8-18. Anthropometric, DEXA scans and endocrine data were collected. BMD z-scores were adjusted for ...

ea0084ps3-15-133 | Thyroid Cancer Diagnosis & Treatment | ETA2022

European thyroid association guideline on the management of pediatric thyroid nodules and thyroid carcinoma

Lebbink Chantal A. , Links Thera P , Czarniecka Agnieszka , P Dias Renuka , Elisei Rossella , Izatt Louise , Krude Heiko , Lorenz Kerstin , Luster Markus , Newbold Kate , Piccardo Arnoldo , Sobrinho Simoes Manuel , Takano Toru , Paul van Trotsenburg AS , A Verburg Frederik , M van Santen Hanneke

Objectives: At present no European recommendations for the management of pediatric thyroid nodules and differentiated thyroid carcinoma (DTC) exist. Differences in clinical, molecular, and pathological characteristics between pediatric and adult DTC emphasize the need for specific recommendations for the pediatric population.Methods and results: An expert panel was instituted by the executive committee of the European Thyroid Association (ETA) including ...

ea0084op-12-62 | Oral Session 12: Nodules and Diagnostic | ETA2022

Progressive diastolic dysfunction in survivors of pediatric differentiated thyroid carcinoma

Reichert Antoinette , Nies Marloes , tissing wim , Muller Kobold Anneke , Klein Hesselink Marielle , Brouwers A.H. , Havekes Bastiaan , van den heuvel-eibrink marry , van der pal helena , plukker john , Van Santen Hanneke , corssmit eleonora , Teodora Netea-Maier Romana , Peeters Robin , van Dam Eveline , burgerhof johannes , van der Meer Peter , bocca gianni , Links Thera

Background: Pediatric differentiated thyroid cancer (DTC) has an excellent prognosis, but has unknown late effects of treatment. Initial cardiac evaluation showed subclinical diastolic dysfunction in 20% of adult survivors. In this follow-up study, we determined the clinical course of this finding.Methods: This multicenter study, conducted between 2018 and 2020, re-evaluated survivors 5 years after the first evaluation. The primary endpoint was echocardi...